Susquehanna International Group’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-54,003
| Closed | -$495K | – | 14068 |
|
|
2021
Q2 | $495K | Buy |
54,003
+20,154
| +60% | +$117K | ﹤0.01% | 9626 |
|
|
2021
Q1 | $168K | Sell |
33,849
-40,259
| -54% | -$194K | ﹤0.01% | 11563 |
|
|
2020
Q4 | $319K | Buy |
74,108
+10,949
| +17% | +$44.5K | ﹤0.01% | 9145 |
|
|
2020
Q3 | $271K | Buy |
63,159
+33,272
| +111% | +$139K | ﹤0.01% | 8919 |
|
|
2020
Q2 | $134K | Buy |
29,887
+14,345
| +92% | +$64.1K | ﹤0.01% | 9340 |
|
|
2020
Q1 | $62K | Buy |
+15,542
| New | +$132K | ﹤0.01% | 9580 |
|
|
2019
Q4 | – | Sell |
-41,005
| Closed | -$281K | – | 11038 |
|
|
2019
Q3 | $281K | Buy |
41,005
+11,564
| +39% | +$84.8K | ﹤0.01% | 8436 |
|
|
2019
Q2 | $245K | Buy |
+29,441
| New | +$254K | ﹤0.01% | 8718 |
|
|
2019
Q1 | – | Sell |
-21,700
| Closed | -$238K | – | 10237 |
|
|
2018
Q4 | $238K | Buy |
21,700
+7,078
| +48% | +$89.2K | ﹤0.01% | 7429 |
|
|
2018
Q3 | $204K | Sell |
14,622
-18,172
| -55% | -$246K | ﹤0.01% | 8188 |
|
|
2018
Q2 | $349K | Buy |
+32,794
| New | +$320K | ﹤0.01% | 7540 |
|
|
2018
Q1 | – | Sell |
-10,782
| Closed | -$94.6K | – | 10532 |
|
|
2017
Q4 | $102K | Buy |
+10,782
| New | +$84.2K | ﹤0.01% | 8681 |
|
|
2017
Q2 | – | Sell |
-12,720
| Closed | -$90K | – | 10095 |
|
|
2017
Q1 | $90K | Sell |
12,720
-884
| -6% | -$5.54K | ﹤0.01% | 8433 |
|
|
2016
Q4 | $58K | Buy |
+13,604
| New | +$65.8K | ﹤0.01% | 9255 |
|
|
2015
Q4 | – | Sell |
-37,207
| Closed | -$193K | – | 10200 |
|
|
2015
Q3 | $193K | Sell |
37,207
-52,457
| -59% | -$323K | ﹤0.01% | 8740 |
|
|
2015
Q2 | $612K | Buy |
+89,664
| New | +$636K | ﹤0.01% | 7232 |
|
Other funds holding KIN
Susquehanna International Group's KIN Position: Q3 2021 in Review
Susquehanna International Group sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 54,003 shares — an estimated $495K sold.
Susquehanna International Group first reported a position in KIN in Q2 2015 and held it in 16 quarters. The position peaked at $612K in Q2 2015. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Susquehanna International Group reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Susquehanna International Group sold 54,003 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $495K.
- Susquehanna International Group first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 16 quarters.
- Susquehanna International Group's Kindred Biosciences, Inc. position peaked at $612K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.